The negative pressure wound therapy market size has grown strongly in recent years. It will grow from $2.88 billion in 2023 to $3.04 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth observed in the historical period can be attributed to several key factors. This includes the aging population leading to increased demand for healthcare services, concerns regarding hospital-acquired infections prompting the adoption of advanced wound therapies, a rise in surgical procedures necessitating improved wound management techniques, the development of healthcare infrastructure catering to specialized treatments, and evolving reimbursement policies supporting the adoption of advanced wound care technologies. These combined elements played pivotal roles in driving growth during that period within the domain of negative-pressure wound therapy and wound care management.
The negative pressure wound therapy market size is expected to see strongly grown in the next few years. It will grow to $3.84 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. Anticipated growth in the forecast period is expected to be influenced by several key factors. These include the prevalence of lifestyle-related diseases prompting the need for advanced wound care, the rise of home-based healthcare leading to increased demand for accessible wound treatments, a heightened focus on global health crisis preparedness necessitating improved wound management solutions, patient preferences for non-invasive treatments driving innovation in wound therapies, the shift towards value-based healthcare models prioritizing effective and efficient treatments, and a growing incidence of chronic wounds demanding specialized care.
The expanding prevalence of diabetes is poised to drive the growth of the negative pressure wound therapy market. Diabetic foot ulceration (DFU) stands as the most prevalent application area for this therapy. Healing diabetic wounds can be challenging due to reduced oxygenated circulation caused by poor circulation in uncontrolled diabetes. Negative pressure wound therapy offers enhanced graft take-up compared to conventional dressing methods for diabetic patients. As per the International Diabetes Federation (IDF), nearly 463 million individuals worldwide had diabetes in 2020, and the Southeast Asia region anticipates an increase from 88 million in 2020 to nearly 153 million by 2045. This rise in diabetes prevalence significantly fuels the negative pressure wound therapy market.
The increasing frequency of surgical procedures is expected to propel the negative pressure wound therapy (NPWT) market's growth. NPWT has proven efficacy in managing surgical wounds, reducing complications, accelerating healing, and enhancing patient quality of life. Surgeons and healthcare providers favor NPWT for wound care, supported by favorable reimbursement policies. For instance, according to the Organization for Economic Co-operation and Development, the Czech Republic witnessed an 8.4% surge in cataract surgical procedures, totaling 142,670 procedures in 2022 compared to 131,612 in 2021. This surge in surgical procedures acts as a significant driver for the growth of the negative pressure wound therapy market. The surge in technological advancements emerges as a prominent trend shaping the negative pressure wound therapy market. Key companies operating in this sector prioritize technological innovations in NPWT. For instance, in August 2022, 3M introduced the 3M Veraflo Cleanse Choice Complete Dressing Kit for negative pressure wound therapy along with a software upgrade for the 3M V.A.C. Ulta Therapy Unit. These novel offerings aim to streamline care delivery processes for clinicians and improve patient experiences by simplifying dressing changes, making them faster and less painful. The software upgrade automates therapy initiation and incorporates helpful features, while the new dressing kit includes a gentler drape for enhanced patient comfort. These innovations intend to enhance the efficiency and effectiveness of Veraflo Therapy in wound care.
Major players in the negative pressure wound therapy market are innovating by developing new portable and disposable NPWT devices to reinforce their market position. These devices, compact and single-use, apply controlled suction to wounds, aiding in healing by removing excess fluids and promoting optimal conditions for tissue recovery. Their mobility and elimination of complex traditional systems offer convenience. For instance, Advanced Oxygen Therapy Inc. Launched the NEXA Negative Pressure Wound Therapy (NPWT) system in June 2023. This portable, silent, and cost-effective system combines the simplicity of disposable NPWT with the performance features of traditional durable NPWT technology. The NEXA NPWT system aims to enhance wound care performance at a lower cost, combining higher pressure oxygen delivery with non-contact cyclical compression and humidity for chronic wound care and healing.
In March 2021, Direct Healthcare Group, a UK-based provider of pressure care solutions, revealed its acquisition of Talley Group Ltd. For an undisclosed sum. This strategic move aims to bolster Direct Healthcare Group's offerings within the pressure ulcer prevention sector and marks their entry into the negative pressure wound therapy (NPWT) and intermittent pneumatic compression (IPC) therapy markets. Talley Group Ltd., also based in the UK, specializes in electric bed frames, negative pressure wound therapy, IPC solutions, and infection control products.
Major companies operating in the negative pressure wound therapy market report are Devon International Group, ConvaTec Group plc., DeRoyal Industries Inc., Smith & Nephew PLC, Acelity L.P. Inc., Mölnlycke Health Care AB, ATMOS MedizinTechnik GmbH & Co. KG, Cardinal Health Inc., Talley Group Limited, Medela AG, Lohmann & Rauscher GmbH & Co. KG, Triage Meditech Pvt. Ltd., Carilex Medical GmbH, Shandong Weigao Xinsheng Medical Devices Co. Lt, Genadyne Biotechnologies Inc., B. Braun Melsungen AG, Cork Medical LLC, BSN medical GmbH, Investor AB, Olle Larsson Holding AG, PAUL HARTMANN Asia-Pacific Ltd., KCI Licensing Inc., Arjo USA Inc., 3M Company, MPM Medical Inc., Prospera Technologies Inc., Innovative Therapies Inc., Laboratoires URGO, 4L Health Co. Ltd., Pensar Medical LLC, Virchow Biotech Pvt. Ltd., Arobella Medical LLC, Spincare Inc., Ursapharm Arzneimittel GmbH.
North America was the largest region in the negative pressure wound therapy market in 2023. Asia-Pacific is the fastest growing region in the negative pressure wound therapy market share.the regions covered in the negative pressure wound therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, Africa. The countries covered in the negative pressure wound therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The primary product types within negative-pressure wound therapy include conventional NPWT devices and single-use NPWT devices. Conventional NPWT devices comprise a filler, often foam or gauze, covering the wound, a permeable membrane, and tubing connecting the space beneath the membrane to a suction mechanism. These components work together to create negative pressure, aiding in wound healing and management.
The negative pressure wound therapy (NPWT) research report is one of a series of new reports provides negative pressure wound therapy (NPWT) statistics, including negative pressure wound therapy (NPWT) industry global market size, regional shares, competitors with negative pressure wound therapy (NPWT) shares, detailed negative pressure wound therapy (NPWT) segments, market trends and opportunities, and any further data you may need to thrive in the negative pressure wound therapy (NPWT) industry. This negative pressure wound therapy (NPWT) research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The negative-pressure wound therapy (NPWT) market consists of sales of conventional NPWT devices, disposable NPWT devices, and NPWT accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The negative pressure wound therapy market size is expected to see strongly grown in the next few years. It will grow to $3.84 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. Anticipated growth in the forecast period is expected to be influenced by several key factors. These include the prevalence of lifestyle-related diseases prompting the need for advanced wound care, the rise of home-based healthcare leading to increased demand for accessible wound treatments, a heightened focus on global health crisis preparedness necessitating improved wound management solutions, patient preferences for non-invasive treatments driving innovation in wound therapies, the shift towards value-based healthcare models prioritizing effective and efficient treatments, and a growing incidence of chronic wounds demanding specialized care.
The expanding prevalence of diabetes is poised to drive the growth of the negative pressure wound therapy market. Diabetic foot ulceration (DFU) stands as the most prevalent application area for this therapy. Healing diabetic wounds can be challenging due to reduced oxygenated circulation caused by poor circulation in uncontrolled diabetes. Negative pressure wound therapy offers enhanced graft take-up compared to conventional dressing methods for diabetic patients. As per the International Diabetes Federation (IDF), nearly 463 million individuals worldwide had diabetes in 2020, and the Southeast Asia region anticipates an increase from 88 million in 2020 to nearly 153 million by 2045. This rise in diabetes prevalence significantly fuels the negative pressure wound therapy market.
The increasing frequency of surgical procedures is expected to propel the negative pressure wound therapy (NPWT) market's growth. NPWT has proven efficacy in managing surgical wounds, reducing complications, accelerating healing, and enhancing patient quality of life. Surgeons and healthcare providers favor NPWT for wound care, supported by favorable reimbursement policies. For instance, according to the Organization for Economic Co-operation and Development, the Czech Republic witnessed an 8.4% surge in cataract surgical procedures, totaling 142,670 procedures in 2022 compared to 131,612 in 2021. This surge in surgical procedures acts as a significant driver for the growth of the negative pressure wound therapy market. The surge in technological advancements emerges as a prominent trend shaping the negative pressure wound therapy market. Key companies operating in this sector prioritize technological innovations in NPWT. For instance, in August 2022, 3M introduced the 3M Veraflo Cleanse Choice Complete Dressing Kit for negative pressure wound therapy along with a software upgrade for the 3M V.A.C. Ulta Therapy Unit. These novel offerings aim to streamline care delivery processes for clinicians and improve patient experiences by simplifying dressing changes, making them faster and less painful. The software upgrade automates therapy initiation and incorporates helpful features, while the new dressing kit includes a gentler drape for enhanced patient comfort. These innovations intend to enhance the efficiency and effectiveness of Veraflo Therapy in wound care.
Major players in the negative pressure wound therapy market are innovating by developing new portable and disposable NPWT devices to reinforce their market position. These devices, compact and single-use, apply controlled suction to wounds, aiding in healing by removing excess fluids and promoting optimal conditions for tissue recovery. Their mobility and elimination of complex traditional systems offer convenience. For instance, Advanced Oxygen Therapy Inc. Launched the NEXA Negative Pressure Wound Therapy (NPWT) system in June 2023. This portable, silent, and cost-effective system combines the simplicity of disposable NPWT with the performance features of traditional durable NPWT technology. The NEXA NPWT system aims to enhance wound care performance at a lower cost, combining higher pressure oxygen delivery with non-contact cyclical compression and humidity for chronic wound care and healing.
In March 2021, Direct Healthcare Group, a UK-based provider of pressure care solutions, revealed its acquisition of Talley Group Ltd. For an undisclosed sum. This strategic move aims to bolster Direct Healthcare Group's offerings within the pressure ulcer prevention sector and marks their entry into the negative pressure wound therapy (NPWT) and intermittent pneumatic compression (IPC) therapy markets. Talley Group Ltd., also based in the UK, specializes in electric bed frames, negative pressure wound therapy, IPC solutions, and infection control products.
Major companies operating in the negative pressure wound therapy market report are Devon International Group, ConvaTec Group plc., DeRoyal Industries Inc., Smith & Nephew PLC, Acelity L.P. Inc., Mölnlycke Health Care AB, ATMOS MedizinTechnik GmbH & Co. KG, Cardinal Health Inc., Talley Group Limited, Medela AG, Lohmann & Rauscher GmbH & Co. KG, Triage Meditech Pvt. Ltd., Carilex Medical GmbH, Shandong Weigao Xinsheng Medical Devices Co. Lt, Genadyne Biotechnologies Inc., B. Braun Melsungen AG, Cork Medical LLC, BSN medical GmbH, Investor AB, Olle Larsson Holding AG, PAUL HARTMANN Asia-Pacific Ltd., KCI Licensing Inc., Arjo USA Inc., 3M Company, MPM Medical Inc., Prospera Technologies Inc., Innovative Therapies Inc., Laboratoires URGO, 4L Health Co. Ltd., Pensar Medical LLC, Virchow Biotech Pvt. Ltd., Arobella Medical LLC, Spincare Inc., Ursapharm Arzneimittel GmbH.
North America was the largest region in the negative pressure wound therapy market in 2023. Asia-Pacific is the fastest growing region in the negative pressure wound therapy market share.the regions covered in the negative pressure wound therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, Africa. The countries covered in the negative pressure wound therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The primary product types within negative-pressure wound therapy include conventional NPWT devices and single-use NPWT devices. Conventional NPWT devices comprise a filler, often foam or gauze, covering the wound, a permeable membrane, and tubing connecting the space beneath the membrane to a suction mechanism. These components work together to create negative pressure, aiding in wound healing and management.
The negative pressure wound therapy (NPWT) research report is one of a series of new reports provides negative pressure wound therapy (NPWT) statistics, including negative pressure wound therapy (NPWT) industry global market size, regional shares, competitors with negative pressure wound therapy (NPWT) shares, detailed negative pressure wound therapy (NPWT) segments, market trends and opportunities, and any further data you may need to thrive in the negative pressure wound therapy (NPWT) industry. This negative pressure wound therapy (NPWT) research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The negative-pressure wound therapy (NPWT) market consists of sales of conventional NPWT devices, disposable NPWT devices, and NPWT accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary2. Negative Pressure Wound Therapy Market Characteristics3. Negative Pressure Wound Therapy Market Trends and Strategies31. Global Negative Pressure Wound Therapy Market Competitive Benchmarking32. Global Negative Pressure Wound Therapy Market Competitive Dashboard33. Key Mergers and Acquisitions in the Negative Pressure Wound Therapy Market
4. Negative Pressure Wound Therapy Market - Macro Economic Scenario
5. Global Negative Pressure Wound Therapy Market Size and Growth
6. Negative Pressure Wound Therapy Market Segmentation
7. Negative Pressure Wound Therapy Market Regional and Country Analysis
8. Asia-Pacific Negative Pressure Wound Therapy Market
9. China Negative Pressure Wound Therapy Market
10. India Negative Pressure Wound Therapy Market
11. Japan Negative Pressure Wound Therapy Market
12. Australia Negative Pressure Wound Therapy Market
13. Indonesia Negative Pressure Wound Therapy Market
14. South Korea Negative Pressure Wound Therapy Market
15. Western Europe Negative Pressure Wound Therapy Market
16. UK Negative Pressure Wound Therapy Market
17. Germany Negative Pressure Wound Therapy Market
18. France Negative Pressure Wound Therapy Market
19. Italy Negative Pressure Wound Therapy Market
20. Spain Negative Pressure Wound Therapy Market
21. Eastern Europe Negative Pressure Wound Therapy Market
22. Russia Negative Pressure Wound Therapy Market
23. North America Negative Pressure Wound Therapy Market
24. USA Negative Pressure Wound Therapy Market
25. Canada Negative Pressure Wound Therapy Market
26. South America Negative Pressure Wound Therapy Market
27. Brazil Negative Pressure Wound Therapy Market
28. Middle East Negative Pressure Wound Therapy Market
29. Africa Negative Pressure Wound Therapy Market
30. Negative Pressure Wound Therapy Market Competitive Landscape and Company Profiles
34. Negative Pressure Wound Therapy Market Future Outlook and Potential Analysis
35. Appendix
Executive Summary
Negative Pressure Wound Therapy Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on negative pressure wound therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for negative pressure wound therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Report Scope
Markets Covered:
1) by Product: Conventional NPWT Devices; Single Use NPWT Devices2) by Wound Type: Surgical and Traumatic Wounds; Ulcers; Burns
3) by End User: Hospitals; Homecare; Other End-Users
Key Companies Mentioned: Devon International Group; ConvaTec Group plc.; DeRoyal Industries Inc.; Smith & Nephew plc; Acelity L.P. Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Delivery Format: PDF, Word and Excel Data Dashboard
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Devon International Group
- ConvaTec Group plc.
- DeRoyal Industries Inc.
- Smith & Nephew plc
- Acelity L.P. Inc.
- Mölnlycke Health Care AB
- ATMOS MedizinTechnik GmbH & Co. KG
- Cardinal Health Inc.
- Talley Group Limited
- Medela AG
- Lohmann & Rauscher GmbH & Co. KG
- Triage Meditech Pvt. Ltd.
- Carilex Medical GmbH
- Shandong Weigao Xinsheng Medical Devices Co. Lt
- Genadyne Biotechnologies Inc.
- B. Braun Melsungen AG
- Cork Medical LLC
- BSN medical GmbH
- Investor AB
- Olle Larsson Holding AG
- PAUL HARTMANN Asia-Pacific Ltd.
- KCI Licensing Inc.
- Arjo USA Inc.
- 3M Company
- MPM Medical Inc.
- Prospera Technologies Inc.
- Innovative Therapies Inc.
- Laboratoires URGO
- 4L Health Co. Ltd
- Pensar Medical LLC
- Virchow Biotech Pvt. Ltd.
- Arobella Medical LLC
- Spincare Inc.
- Ursapharm Arzneimittel GmbH
Methodology
LOADING...
